OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Treatment of Advanced Prostate Cancer: Expert Evaluations of Recent Studies

home / peer-exchange / advanced-prostate-cancer
Use of AR-V7 as a Prostate Cancer Biomarker

EP. 1: Use of AR-V7 as a Prostate Cancer Biomarker

November 30th 2015
Novel Prostate Cancer Biomarkers

EP. 2: Novel Prostate Cancer Biomarkers

November 30th 2015
Importance of Molecular Changes in Prostate Cancer

EP. 3: Importance of Molecular Changes in Prostate Cancer

November 30th 2015
AR Targeted Therapy for Nonmetastatic CRPC

EP. 4: AR Targeted Therapy for Nonmetastatic CRPC

November 30th 2015
Managing mCRPC Patients on Abiraterone

EP. 5: Managing mCRPC Patients on Abiraterone

November 30th 2015
Early Treatment Approaches in Prostate Cancer

EP. 6: Early Treatment Approaches in Prostate Cancer

November 30th 2015
Benefits of Radiopharmaceuticals in mCRPC

EP. 7: Benefits of Radiopharmaceuticals in mCRPC

November 30th 2015
Managing Pain in Patients with Prostate Cancer

EP. 8: Managing Pain in Patients with Prostate Cancer

November 30th 2015
Monitoring During Radium-223 Treatment in Prostate Cancer

EP. 9: Monitoring During Radium-223 Treatment in Prostate Cancer

November 30th 2015
The Role of Sipuleucel-T in Advanced Prostate Cancer

EP. 10: The Role of Sipuleucel-T in Advanced Prostate Cancer

November 30th 2015
Costs Associated with Prostate Cancer Treatment

EP. 11: Costs Associated with Prostate Cancer Treatment

November 30th 2015
Hormone-Sensitive Metastatic Prostate Cancer

EP. 12: Hormone-Sensitive Metastatic Prostate Cancer

November 30th 2015
Impact of Volume of Disease in Prostate Cancer

EP. 13: Impact of Volume of Disease in Prostate Cancer

November 30th 2015
Cabazitaxel Use in Metastatic Prostate Cancer

EP. 14: Cabazitaxel Use in Metastatic Prostate Cancer

November 30th 2015

Latest Conference Coverage

Poll Results Punctuate Key Lung Cancer Abstracts Driving Intrigue Ahead of ASCO 2025

Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study

Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial

Ultra-Low PSA Response With Darolutamide/ADT Correlates With Better Outcomes in mHSPC

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact